The implications of the shared genetics of psychiatric disorders

Nature Medicine

Volumn 22, Issue 11, 2016, Pages 1214-1219

  O'Donovan, Michael C ^a   Owen, Michael J ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ALLELE; DEVELOPMENTAL DISORDER; GENETICS; HUMAN; MENTAL DISEASE; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHIATRY; REVIEW; VALIDITY; AUTISM; BIPOLAR DISORDER; GENETIC PREDISPOSITION; MAJOR DEPRESSION; SCHIZOPHRENIA;

ALLELES; AUTISM SPECTRUM DISORDER; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; GENETIC PLEIOTROPY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MENTAL DISORDERS; SCHIZOPHRENIA;

EID: 84992337495     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.4196     Document Type: Review

References (44)

1. Whiteford, H.A. et al. Global burden of disease attributable to mental and substance use disorders: fndings from the Global Burden of Disease Study 2010. Lancet 382, 1575-1586 (2013).
2. Salomon, J.A. et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 380, 2129-2143 (2012).
3. Owen, M.J. New approaches to psychiatric diagnostic classifcation. Neuron 84, 564-571 (2014).
4. Malaspina, D. et al. Schizoaffective disorder in the DSM-5. Schizophr. Res. 150, 21-25 (2013).
5. van Os, J. & Kapur, S. Schizophrenia. Lancet 374, 635-645 (2009).
6. Lichtenstein, P. et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 373, 234-239 (2009).
7. Kapur, S., Phillips, A.G. & Insel, T.R. Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? Mol. Psychiatry 17, 1174-1179 (2012).
8. Linden, D.E. The challenges and promise of neuroimaging in psychiatry. Neuron 73, 8-22 (2012).
9. Sanders, S.J. et al. Insights into autism spectrum disorder genomic architecture and biology from 71 risk loci. Neuron 87, 1215-1233 (2015).
10. Gaugler, T. et al. Most genetic risk for autism resides with common variation. Nat. Genet. 46, 881-885 (2014).
11. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421-427 (2014).
12. Rees, E. et al. Analysis of copy number variations at 15 schizophrenia-associated loci. Br. J. Psychiatry 204, 108-114 (2014).
13. Fromer, M. et al. De novo mutations in schizophrenia implicate synaptic networks. Nature 506, 179-184 (2014).
14. Purcell, S.M. et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 506, 185-190 (2014).
15. Singh, T. et al. Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders. Nat. Neurosci. 19, 571-577 (2016).
16. Green, E.K. et al. Copy number variation in bipolar disorder. Mol. Psychiatry 21, 89-93 (2016).
17. Hyde, C.L. et al. Identifcation of 15 genetic loci associated with risk of major depression in individuals of European descent. Nat. Genet. 48, 1031-1036 (2016).
18. Paaby, A.B. & Rockman, M.V. The many faces of pleiotropy. Trends Genet. 29, 66-73 (2013).
19. Solovieff, N., Cotsapas, C., Lee, P.H., Purcell, S.M. & Smoller, J.W. Pleiotropy in complex traits: challenges and strategies. Nat. Rev. Genet. 14, 483-495 (2013).
20. Kirov, G. et al. The penetrance of copy number variations for schizophrenia and developmental delay. Biol. Psychiatry 75, 378-385 (2014).
21. Rees, E. et al. Analysis of intellectual disability copy number variants for association with schizophrenia. JAMA Psychiatry 73, 963-969 (2016).
22. Rujescu, D. et al. Disruption of the neurexin 1 gene is associated with schizophrenia. Hum. Mol. Genet. 18, 988-996 (2009).
23. Deciphering Developmental Disorders Study. Large-scale discovery of novel genetic causes of developmental disorders. Nature 519, 223-228 (2015).
24. The International Schizophrenia Consortium. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748-752 (2009).
25. Cross-Disorder Group of the Psychiatric Genomics Consortium. Genetic relationship between fve psychiatric disorders estimated from genome-wide SNPs. Nat. Genet. 45, 984-994 (2013).
26. Bulik-Sullivan, B. et al. An atlas of genetic correlations across human diseases and traits. Nat. Genet. 47, 1236-1241 (2015).
27. Hamshere, M.L. et al. Shared polygenic contribution between childhood attention-defcit hyperactivity disorder and adult schizophrenia. Br. J. Psychiatry 203, 107-111 (2013).
28. Samocha, K.E. et al. A framework for the interpretation of de novo mutation in human disease. Nat. Genet. 46, 944-950 (2014).
29. Kirov, G. et al. De novo CNV analysis implicates specifc abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol. Psychiatry 17, 142-153 (2012).
30. Niarchou, M. et al. Psychopathology and cognition in children with 22q11.2 deletion syndrome. Br. J. Psychiatry 204, 46-54 (2014).
31. Stefansson, H. et al. CNVs conferring risk of autism or schizophrenia affect cognition in controls. Nature 505, 361-366 (2014).
32. Tansey, K.E. et al. Common alleles contribute to schizophrenia in CNV carriers. Mol. Psychiatr. 21, 1085-1089 (2015).
33. Rees, E. et al. Evidence that duplications of 22q11.2 protect against schizophrenia. Mol. Psychiatry 19, 37-40 (2014).
34. Cross-Disorder Group of the Psychiatric Genomics Consortium. Genetic relationship between fve psychiatric disorders estimated from genome-wide SNPs. Nat. Genet. 45, 984-994 (2012).
35. Costain, G. et al. Pathogenic rare copy number variants in community-based schizophrenia suggest a potential role for clinical microarrays. Hum. Mol. Genet. 22, 4485-4501 (2013).
36. Gershon, E.S. & Alliey-Rodriguez, N. New ethical issues for genetic counseling in common mental disorders. Am. J. Psychiatry 170, 968-976 (2013).
37. Walters, J.T.R. & Owen, M.J. Endophenotypes in psychiatric genetics. Mol. Psychiatry 12, 886-890 (2007).
38. Kendler, K.S. & Neale, M.C. Endophenotype: a conceptual analysis. Mol. Psychiatr 15, 789-797 (2010).
39. Antilla, V. et al. Analysis of shared heritability in common disorders of the brain. Preprint at bioRxiv http://dx.doi.org/10.1101/048991 (2016).
40. Ruderfer, D.M. et al. A family-based study of common polygenic variation and risk of schizophrenia. Mol. Psychiatry 16, 887-888 (2011).
41. Hamshere, M.L. et al. Genome-wide signifcant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC. Mol. Psychiatry 18, 708-712 (2013).
42. Flint, J., Timpson, N. & Munafò, M. Assessing the utility of intermediate phenotypes for genetic mapping of psychiatric disease. Trends Neurosci. 37, 733-741 (2014).
43. Franke, B. et al. Genetic infuences on schizophrenia and subcortical brain volumes: large-scale proof of concept. Nat. Neurosci. 19, 420-431 (2016).
44. Cuthbert, B.N. The RDoC framework: facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology. World Psychiatry 13, 28-35 (2014).